This includes procedures that cover all relatedoperations: process monitoring and record keeping, regular review of processes,and ongoing system improvement. “With this certification, Jupiter Systems will continue to build and manufactureproducts that provide the highest level of quality, functionality andperformance,” said Kelley. Total customer satisfaction throughcontinuous improvement is the goal of Jupiter Systems.” ISO 9001:2008 certification indicates that Jupiter Systems has achieved industrybest practices for quality management, effectively measuring and improvinglevels of customer satisfaction, and demonstrating consistently the measuresrequired to provide a product that meets all customer applicable statutory andregulatory requirements. This newcertification recognizes our efforts and the importance we place on deliveringthe highest standard of quality management. “We are very pleased to announce this milestone achievement,” said Charles F.”Chuck” Kelley, Vice President of Operations.

“Jupiter has made qualitymanagement and control a top priority for its worldwide operations. Jupiter was initially certified in2005 under the earlier ISO 9001: 2000 standard. Edge Communications, Inc.Ken Greenberg, Copyright Business Wire 2009. Award Recognizes Jupiter`s Meeting the Highest Standards of Industry BestPractices for Quality Management and ControlHAYWARD, Calif.–(Business Wire)–Jupiter Systems (), the industry leader in display wallprocessors, today announced that it has achieved ISO 9001:2008 certification forquality management and quality assurance. The organization was founded by Dr.Renee Kaswan, inventor of the billion-dollar drug Restasis and a former researchprofessor at the University of Georgia; and is led by executive director RhazZeisler, a recognized international interactive media brand strategist, andformer Walt Disney producer and IBM creative executive IP Advocate is a501(c)(3) organization, based in Atlanta.

IPAdvocate is a rich resource of information and best practices related to thecommercialization of intellectual property. About IP AdvocateIP Advocate () is a non-profit organization that educates andempowers faculty researchers on patent rights and the process ofcommercialization – helping inventors protect their rights during the complexprocess of getting their invention from the lab to the people who need it. Last month, IPAdvocate won the Interactive MediaAward for Outstanding Achievement in Advocacy. Since its May launch, IPAdvocate has won two “Communicator Awards ofDistinction” from the International Academy of the Visual Arts in the categoriesof Education and Branding. “This section launch represents another significant step in our mission todevelop topical, informative content and continue to add more interactiveresources to our online community,” said IPAdvocate Executive Director, RhazZeisler, a recognized industry innovator of multi-channel interactive new mediaand digital branding. “A few simplemodifications?..would likely generate significant outcomes,” Dr Mermelsteinwrites.

“These include dedicating a minimal amount of grant funds to cover costsassociated with filing a U.S. patent application to increase interaction betweenfunded laboratories and their technology transfer offices and corporationsinterested in commercial development of research.” Already one of the most comprehensive IP resources available, IPAdvocate provides a storehouse of authoritative information on laws and litigationrelated to intellectual property issues, case studies that represent bothcautionary tales and examples of commercialization done right, and aninteractive forum where researchers and others can share information with eachother and discuss laws, ethics, best practices, public policy on academictechnology transfer and more. Another “Expert Opinions” contributor, Fred Mermelstein, PhD., ExecutiveDirector of Javelin Pharmaceuticals, Inc., discusses how NIH-sponsored researchcould be advanced and more efficiently leveraged. “Under no instancesshould an employee be required to assign an invention to a university orcorporation until due diligence has been performed to determine whether theinvention was truly within the scope of his/her job,” Dr Suppes notes. Suppes titled “Critical Issues inUniversity Intellectual Property,” covers job scope issues and best practices inprovisional patent applications in a university setting.

Suppesdiscovered an environmentally friendly use of glycerin, the co-product ofbiodiesel production, and is currently fighting the University for the rights toseveral of his inventions The Q&A with Dr. “As profits rise, business interests oftentrample on the rightful professional and personal interests of facultyinventors. Our goal is to help researchers navigate the difficult process ofcommercialization.” “Expert Opinions” currently features a Q&A with Galen Suppes, Ph.D., Professorof Chemical Engineering at the University of Missouri-Columbia Dr. Renee Kaswan, founder of IP Advocate,former research professor at the University of Georgia and inventor of thebillion-dollar drug Restasis®.